These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2140463

  • 1. Liposome-incorporated 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine as a slow-release anti-tumor drug depot in rat liver macrophages.
    Van Borssum Waalkes M, Scherphof GL.
    Sel Cancer Ther; 1990; 6(1):15-22. PubMed ID: 2140463
    [Abstract] [Full Text] [Related]

  • 2. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.
    van Borssum Waalkes M, van Galen M, Morselt H, Sternberg B, Scherphof GL.
    Biochim Biophys Acta; 1993 May 14; 1148(1):161-72. PubMed ID: 8499464
    [Abstract] [Full Text] [Related]

  • 3. 5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine--novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results.
    Schwendener RA, Supersaxo A, Rubas W, Weder HG, Hartmann HR, Schott H, Ziegler A, Hengartner H.
    Biochem Biophys Res Commun; 1985 Jan 31; 126(2):660-6. PubMed ID: 3156589
    [Abstract] [Full Text] [Related]

  • 4. In vivo distribution and antitumour activity of liposomal 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine.
    Van Borssum Waalkes M, Fichtner I, Dontje B, Lemm M, Becker M, Arndt D, Scherphof GL.
    J Microencapsul; 1992 Jan 31; 9(3):335-46. PubMed ID: 1403484
    [Abstract] [Full Text] [Related]

  • 5. The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomes.
    Supersaxo A, Rubas W, Hartmann HR, Schott H, Hengartner H, Schwendener RA.
    J Microencapsul; 1988 Jan 31; 5(1):1-11. PubMed ID: 2974073
    [Abstract] [Full Text] [Related]

  • 6. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
    Mori A, Kennel SJ, van Borssum Waalkes M, Scherphof GL, Huang L.
    Cancer Chemother Pharmacol; 1995 Jan 31; 35(6):447-56. PubMed ID: 7882453
    [Abstract] [Full Text] [Related]

  • 7. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.
    Koning GA, Gorter A, Scherphof GL, Kamps JA.
    Br J Cancer; 1999 Aug 31; 80(11):1718-25. PubMed ID: 10468287
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
    Xia Z, Wiebe LI, Miller GG, Knaus EE.
    Arch Pharm (Weinheim); 1999 Aug 31; 332(8):286-94. PubMed ID: 10489539
    [Abstract] [Full Text] [Related]

  • 9. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
    Mori A, Kennel SJ, Huang L.
    Pharm Res; 1993 Apr 31; 10(4):507-14. PubMed ID: 8483832
    [Abstract] [Full Text] [Related]

  • 10. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
    Koning GA, Morselt HW, Velinova MJ, Donga J, Gorter A, Allen TM, Zalipsky S, Kamps JA, Scherphof GL.
    Biochim Biophys Acta; 1999 Aug 20; 1420(1-2):153-67. PubMed ID: 10446299
    [Abstract] [Full Text] [Related]

  • 11. Effect of cholesterol on the uptake and intracellular degradation of liposomes by liver and spleen; a combined biochemical and gamma-ray perturbed angular correlation study.
    Roerdink FH, Regts J, Handel T, Sullivan SM, Baldeschwieler JD, Scherphof GL.
    Biochim Biophys Acta; 1989 Apr 14; 980(2):234-40. PubMed ID: 2930790
    [Abstract] [Full Text] [Related]

  • 12. Toxicity of liposomal 3'-5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in mice.
    van Borssum Waalkes M, Goris H, Dontje BH, Schwendener RA, Scherphof G, Nijhof W.
    Anticancer Drug Des; 1998 Jun 14; 13(4):291-305. PubMed ID: 9627669
    [Abstract] [Full Text] [Related]

  • 13. Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages.
    Derksen JT, Morselt HW, Scherphof GL.
    Biochim Biophys Acta; 1988 Sep 16; 971(2):127-36. PubMed ID: 2844282
    [Abstract] [Full Text] [Related]

  • 14. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G, Roerdink FH, Steerenberg PA, de Jong WH, Crommelin DJ.
    Cancer Res; 1987 Jul 01; 47(13):3366-72. PubMed ID: 3581073
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activity of novel 5-fluoro-2'-deoxyuridine phosphoramidate prodrugs.
    Freel Meyers CL, Hong L, Joswig C, Borch RF.
    J Med Chem; 2000 Nov 02; 43(22):4313-8. PubMed ID: 11063625
    [Abstract] [Full Text] [Related]

  • 16. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
    Koning GA, Kamps JA, Scherphof GL.
    Cancer Detect Prev; 2002 Nov 02; 26(4):299-307. PubMed ID: 12430634
    [Abstract] [Full Text] [Related]

  • 17. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL, Davidsen J, Begtrup M, Mouritsen OG, Jørgensen K.
    J Med Chem; 2004 Mar 25; 47(7):1694-703. PubMed ID: 15027860
    [Abstract] [Full Text] [Related]

  • 18. Conversion of liposomal 5-fluoro-2'-deoxyuridine and its dipalmitoyl derivative to bile acid conjugates of alpha-fluoro-beta-alanine and their excretion into rat bile.
    van Borssum Waalkes M, Kuipers F, Havinga R, Scherphof GL.
    Biochim Biophys Acta; 1993 Mar 10; 1176(1-2):43-50. PubMed ID: 8452878
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages on tumor cells.
    Zeisig R, Jungmann S, Fichtner I, Daemen T, Arndt D.
    Anticancer Res; 1994 Mar 10; 14(5A):1785-9. PubMed ID: 7847811
    [Abstract] [Full Text] [Related]

  • 20. Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles.
    Wang JX, Sun X, Zhang ZR.
    Eur J Pharm Biopharm; 2002 Nov 10; 54(3):285-90. PubMed ID: 12445558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.